{"podcast":{"title":"Hims House","slug":"hims-house-7026583","podcast_index_feed_id":7026583,"rss_url":"https://anchor.fm/s/10e9c0874/podcast/rss","website_url":"https://himshouse.substack.com/podcast","image_url":"https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/45300741/1466fea8bed61dc7.jpg","author":"Jonathan Stern","episode_count":73,"summary":"Hims House is the ultimate podcast for Hims & Hers investors. Hosted by Jonathan Stern and Patrick Lester, Hims House breaks down all the key questions shaping $HIMS — from telehealth and pharma to GLP-1s, compounding, and the future of healthcare. New episodes every week. himshouse.substack.com","last_synced_at":"2026-07-08T00:20:15.279819+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583"},"episodes":[{"title":"Ryan MacDonald: Peptides could be a $30B+ market, and Hims is positioned to win meaningful share","slug":"ryan-macdonald-peptides-could-be-a-30b-market-and-hims-is-positioned-to-win-meaningful-share","published_at":"2026-07-07T11:33:01+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583/ryan-macdonald-peptides-could-be-a-30b-market-and-hims-is-positioned-to-win-meaningful-share","url":"https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/Ryan-MacDonald-Peptides-could-be-a-30B-market--and-Hims-is-positioned-to-win-meaningful-share-e3lo7si","duration_seconds":3630,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/ryan-macdonald-peptides-could-be-a-30b-market-and-hims-is-positioned-to-win-meaningful-share/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hims-house-7026583/ryan-macdonald-peptides-could-be-a-30b-market-and-hims-is-positioned-to-win-meaningful-share.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"🚨 EXCLUSIVE: Hims board member David Wells on why he bought $1.2M of Hims","slug":"exclusive-hims-board-member-david-wells-on-why-he-bought-1-2m-of-hims","published_at":"2026-07-01T11:30:54+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583/exclusive-hims-board-member-david-wells-on-why-he-bought-1-2m-of-hims","url":"https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/EXCLUSIVE-Hims-board-member-David-Wells-on-why-he-bought-1-2M-of-Hims-e3lgh97","duration_seconds":3083,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/exclusive-hims-board-member-david-wells-on-why-he-bought-1-2m-of-hims/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hims-house-7026583/exclusive-hims-board-member-david-wells-on-why-he-bought-1-2m-of-hims.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Hedge funder Ignacio Canto on retail cults, Hims as Costco + Netflix, and why Hims has 10x upside","slug":"hedge-funder-ignacio-canto-on-retail-cults-hims-as-costco-netflix-and-why-hims-has-10x-upside","published_at":"2026-06-24T12:15:00+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583/hedge-funder-ignacio-canto-on-retail-cults-hims-as-costco-netflix-and-why-hims-has-10x-upside","url":"https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/Hedge-funder-Ignacio-Canto-on-retail-cults--Hims-as-Costco--Netflix--and-why-Hims-has-10x-upside-e3l6tj9","duration_seconds":4023,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/hedge-funder-ignacio-canto-on-retail-cults-hims-as-costco-netflix-and-why-hims-has-10x-upside/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hims-house-7026583/hedge-funder-ignacio-canto-on-retail-cults-hims-as-costco-netflix-and-why-hims-has-10x-upside.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Hedge fund manager Imran Khan bought more Hims at its most hated moment -- here's why","slug":"hedge-fund-manager-imran-khan-bought-more-hims-at-its-most-hated-moment-here-s-why","published_at":"2026-06-16T12:00:00+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583/hedge-fund-manager-imran-khan-bought-more-hims-at-its-most-hated-moment-here-s-why","url":"https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/Hedge-fund-manager-Imran-Khan-bought-more-Hims-at-its-most-hated-moment----heres-why-e3kr7db","duration_seconds":3230,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/hedge-fund-manager-imran-khan-bought-more-hims-at-its-most-hated-moment-here-s-why/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hims-house-7026583/hedge-fund-manager-imran-khan-bought-more-hims-at-its-most-hated-moment-here-s-why.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Cremieux - Half of America could be on GLP-1s by 2030 (and why peptides are probably overhyped)","slug":"cremieux-half-of-america-could-be-on-glp-1s-by-2030-and-why-peptides-are-probably-overhyped","published_at":"2026-06-10T12:43:33+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583/cremieux-half-of-america-could-be-on-glp-1s-by-2030-and-why-peptides-are-probably-overhyped","url":"https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/Cremieux---Half-of-America-could-be-on-GLP-1s-by-2030-and-why-peptides-are-probably-overhyped-e3kjl3i","duration_seconds":2908,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/cremieux-half-of-america-could-be-on-glp-1s-by-2030-and-why-peptides-are-probably-overhyped/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hims-house-7026583/cremieux-half-of-america-could-be-on-glp-1s-by-2030-and-why-peptides-are-probably-overhyped.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Sagar & Sahil Chopra - Founders of Empower Sleep on AI-powered sleep care and the Hims opportunity","slug":"sagar-sahil-chopra-founders-of-empower-sleep-on-ai-powered-sleep-care-and-the-hims-opportunity","published_at":"2026-05-26T12:23:59+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583/sagar-sahil-chopra-founders-of-empower-sleep-on-ai-powered-sleep-care-and-the-hims-opportunity","url":"https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/Sagar--Sahil-Chopra---Founders-of-Empower-Sleep-on-AI-powered-sleep-care-and-the-Hims-opportunity-e3jtlbd","duration_seconds":3297,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/sagar-sahil-chopra-founders-of-empower-sleep-on-ai-powered-sleep-care-and-the-hims-opportunity/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hims-house-7026583/sagar-sahil-chopra-founders-of-empower-sleep-on-ai-powered-sleep-care-and-the-hims-opportunity.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Eli Dorf (Bask Health) - What is Hims’ moat if anyone can launch a telehealth startup overnight?","slug":"eli-dorf-bask-health-what-is-hims-moat-if-anyone-can-launch-a-telehealth-startup-overnight","published_at":"2026-05-19T12:00:00+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583/eli-dorf-bask-health-what-is-hims-moat-if-anyone-can-launch-a-telehealth-startup-overnight","url":"https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/Eli-Dorf-Bask-Health---What-is-Hims-moat-if-anyone-can-launch-a-telehealth-startup-overnight-e3jia0r","duration_seconds":3353,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/eli-dorf-bask-health-what-is-hims-moat-if-anyone-can-launch-a-telehealth-startup-overnight/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hims-house-7026583/eli-dorf-bask-health-what-is-hims-moat-if-anyone-can-launch-a-telehealth-startup-overnight.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Brian Birnbaum - Hims & Hers Q1 earnings breakdown and the long-term bull case for Hims","slug":"brian-birnbaum-hims-hers-q1-earnings-breakdown-and-the-long-term-bull-case-for-hims","published_at":"2026-05-13T12:00:00+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583/brian-birnbaum-hims-hers-q1-earnings-breakdown-and-the-long-term-bull-case-for-hims","url":"https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/Brian-Birnbaum---Hims--Hers-Q1-earnings-breakdown-and-the-long-term-bull-case-for-Hims-e3j9oks","duration_seconds":3563,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/brian-birnbaum-hims-hers-q1-earnings-breakdown-and-the-long-term-bull-case-for-hims/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hims-house-7026583/brian-birnbaum-hims-hers-q1-earnings-breakdown-and-the-long-term-bull-case-for-hims.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Mansi Hukmani - The #1 peptide Substacker on peptide culture, supply-chain race & coming gold rush","slug":"mansi-hukmani-the-1-peptide-substacker-on-peptide-culture-supply-chain-race-coming-gold-rush","published_at":"2026-04-30T12:00:00+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583/mansi-hukmani-the-1-peptide-substacker-on-peptide-culture-supply-chain-race-coming-gold-rush","url":"https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/Mansi-Hukmani---The-1-peptide-Substacker-on-peptide-culture--supply-chain-race--coming-gold-rush-e3im5k6","duration_seconds":3011,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/mansi-hukmani-the-1-peptide-substacker-on-peptide-culture-supply-chain-race-coming-gold-rush/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hims-house-7026583/mansi-hukmani-the-1-peptide-substacker-on-peptide-culture-supply-chain-race-coming-gold-rush.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Enhanced Games - \"We're ready to go\" on peptides, prepping $1.2B SPAC in May","slug":"enhanced-games-we-re-ready-to-go-on-peptides-prepping-1-2b-spac-in-may","published_at":"2026-04-27T12:00:00+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583/enhanced-games-we-re-ready-to-go-on-peptides-prepping-1-2b-spac-in-may","url":"https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/Enhanced-Games---Were-ready-to-go-on-peptides--prepping-1-2B-SPAC-in-May-e3igmia","duration_seconds":4459,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/enhanced-games-we-re-ready-to-go-on-peptides-prepping-1-2b-spac-in-may/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hims-house-7026583/enhanced-games-we-re-ready-to-go-on-peptides-prepping-1-2b-spac-in-may.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"David Maris - The billion-dollar opportunity for Hims that Wall Street is \"sleeping\" on","slug":"david-maris-the-billion-dollar-opportunity-for-hims-that-wall-street-is-sleeping-on","published_at":"2026-04-22T12:44:57+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583/david-maris-the-billion-dollar-opportunity-for-hims-that-wall-street-is-sleeping-on","url":"https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/David-Maris---The-billion-dollar-opportunity-for-Hims-that-Wall-Street-is-sleeping-on-e3i9k90","duration_seconds":4176,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/david-maris-the-billion-dollar-opportunity-for-hims-that-wall-street-is-sleeping-on/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hims-house-7026583/david-maris-the-billion-dollar-opportunity-for-hims-that-wall-street-is-sleeping-on.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Jonah Lupton - Why peptides are so bullish for Hims & Hers","slug":"jonah-lupton-why-peptides-are-so-bullish-for-hims-hers","published_at":"2026-04-17T19:47:52+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583/jonah-lupton-why-peptides-are-so-bullish-for-hims-hers","url":"https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/Jonah-Lupton---Why-peptides-are-so-bullish-for-Hims--Hers-e3i2g61","duration_seconds":3518,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/jonah-lupton-why-peptides-are-so-bullish-for-hims-hers/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hims-house-7026583/jonah-lupton-why-peptides-are-so-bullish-for-hims-hers.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Geoff Cook (Noom CEO) - The peptide boom and why Noom just acquired a 503A pharmacy","slug":"geoff-cook-noom-ceo-the-peptide-boom-and-why-noom-just-acquired-a-503a-pharmacy","published_at":"2026-04-01T13:03:30+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583/geoff-cook-noom-ceo-the-peptide-boom-and-why-noom-just-acquired-a-503a-pharmacy","url":"https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/Geoff-Cook-Noom-CEO---The-peptide-boom-and-why-Noom-just-acquired-a-503A-pharmacy-e3h8su0","duration_seconds":3230,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/geoff-cook-noom-ceo-the-peptide-boom-and-why-noom-just-acquired-a-503a-pharmacy/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hims-house-7026583/geoff-cook-noom-ceo-the-peptide-boom-and-why-noom-just-acquired-a-503a-pharmacy.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Sam Koppelman - Why Hunterbrook’s founder says Hims \"wiped the floor\" with Novo","slug":"sam-koppelman-why-hunterbrook-s-founder-says-hims-wiped-the-floor-with-novo","published_at":"2026-03-16T12:30:00+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583/sam-koppelman-why-hunterbrook-s-founder-says-hims-wiped-the-floor-with-novo","url":"https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/Sam-Koppelman---Why-Hunterbrooks-founder-says-Hims-wiped-the-floor-with-Novo-e3ggf05","duration_seconds":2246,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/sam-koppelman-why-hunterbrook-s-founder-says-hims-wiped-the-floor-with-novo/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hims-house-7026583/sam-koppelman-why-hunterbrook-s-founder-says-hims-wiped-the-floor-with-novo.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"🚨 NOVO NORDISK AND HIMS & HERS STRIKE A NEW DEAL — Raul Shah breaks it all down","slug":"novo-nordisk-and-hims-hers-strike-a-new-deal-raul-shah-breaks-it-all-down","published_at":"2026-03-10T11:30:00+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583/novo-nordisk-and-hims-hers-strike-a-new-deal-raul-shah-breaks-it-all-down","url":"https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/NOVO-NORDISK-AND-HIMS--HERS-STRIKE-A-NEW-DEAL--Raul-Shah-breaks-it-all-down-e3g6upc","duration_seconds":3604,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/novo-nordisk-and-hims-hers-strike-a-new-deal-raul-shah-breaks-it-all-down/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hims-house-7026583/novo-nordisk-and-hims-hers-strike-a-new-deal-raul-shah-breaks-it-all-down.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Mark Mulhern - Hims & Hers Q4 Earnings Recap & Breakdown","slug":"mark-mulhern-hims-hers-q4-earnings-recap-breakdown","published_at":"2026-03-02T15:00:25+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583/mark-mulhern-hims-hers-q4-earnings-recap-breakdown","url":"https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/Mark-Mulhern---Hims--Hers-Q4-Earnings-Recap--Breakdown-e3fqoun","duration_seconds":3689,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/mark-mulhern-hims-hers-q4-earnings-recap-breakdown/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hims-house-7026583/mark-mulhern-hims-hers-q4-earnings-recap-breakdown.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Annanay Kapila - Former quant on why Hims is the most-shorted stock in the S&P MidCap 400 🤯","slug":"annanay-kapila-former-quant-on-why-hims-is-the-most-shorted-stock-in-the-s-p-midcap-400","published_at":"2026-02-18T17:30:14+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583/annanay-kapila-former-quant-on-why-hims-is-the-most-shorted-stock-in-the-s-p-midcap-400","url":"https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/Annanay-Kapila---Former-quant-on-why-Hims-is-the-most-shorted-stock-in-the-SP-MidCap-400-e3f91vi","duration_seconds":3692,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/annanay-kapila-former-quant-on-why-hims-is-the-most-shorted-stock-in-the-s-p-midcap-400/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hims-house-7026583/annanay-kapila-former-quant-on-why-hims-is-the-most-shorted-stock-in-the-s-p-midcap-400.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Myra Ahmad (Founder & CEO of Mochi Health) - The future of GLP-1s","slug":"myra-ahmad-founder-ceo-of-mochi-health-the-future-of-glp-1s","published_at":"2026-02-12T13:00:00+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583/myra-ahmad-founder-ceo-of-mochi-health-the-future-of-glp-1s","url":"https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/Myra-Ahmad-Founder--CEO-of-Mochi-Health---The-future-of-GLP-1s-e3evv8a","duration_seconds":2652,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/myra-ahmad-founder-ceo-of-mochi-health-the-future-of-glp-1s/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hims-house-7026583/myra-ahmad-founder-ceo-of-mochi-health-the-future-of-glp-1s.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"🚨 NOVO NORDISK SUES HIMS & HERS — Patent attorney Gaston Kroub breaks it down","slug":"novo-nordisk-sues-hims-hers-patent-attorney-gaston-kroub-breaks-it-down","published_at":"2026-02-10T21:23:51+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583/novo-nordisk-sues-hims-hers-patent-attorney-gaston-kroub-breaks-it-down","url":"https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/NOVO-NORDISK-SUES-HIMS--HERS--Patent-attorney-Gaston-Kroub-breaks-it-down-e3etpep","duration_seconds":3312,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/novo-nordisk-sues-hims-hers-patent-attorney-gaston-kroub-breaks-it-down/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hims-house-7026583/novo-nordisk-sues-hims-hers-patent-attorney-gaston-kroub-breaks-it-down.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Max Marchione - Peptides, Pharma 2.0, and why Hims could 10x or even 100x 🤯","slug":"max-marchione-peptides-pharma-2-0-and-why-hims-could-10x-or-even-100x","published_at":"2026-02-06T12:36:36+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583/max-marchione-peptides-pharma-2-0-and-why-hims-could-10x-or-even-100x","url":"https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/Max-Marchione---Peptides--Pharma-2-0--and-why-Hims-could-10x-or-even-100x-e3en03q","duration_seconds":2971,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/max-marchione-peptides-pharma-2-0-and-why-hims-could-10x-or-even-100x/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hims-house-7026583/max-marchione-peptides-pharma-2-0-and-why-hims-could-10x-or-even-100x.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"🚨 Hims launches GLP-1 pill, Novo Nordisk threatens to sue!!! (emergency pod with Cremieux)","slug":"hims-launches-glp-1-pill-novo-nordisk-threatens-to-sue-emergency-pod-with-cremieux","published_at":"2026-02-05T23:25:05+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583/hims-launches-glp-1-pill-novo-nordisk-threatens-to-sue-emergency-pod-with-cremieux","url":"https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/Hims-launches-GLP-1-pill--Novo-Nordisk-threatens-to-sue----emergency-pod-with-Cremieux-e3emv1p","duration_seconds":1706,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/hims-launches-glp-1-pill-novo-nordisk-threatens-to-sue-emergency-pod-with-cremieux/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hims-house-7026583/hims-launches-glp-1-pill-novo-nordisk-threatens-to-sue-emergency-pod-with-cremieux.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Sabina Hemmi - The GLP-1 Wars","slug":"sabina-hemmi-the-glp-1-wars","published_at":"2026-02-03T14:40:02+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583/sabina-hemmi-the-glp-1-wars","url":"https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/Sabina-Hemmi---The-GLP-1-Wars-e3eiv16","duration_seconds":3552,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/sabina-hemmi-the-glp-1-wars/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hims-house-7026583/sabina-hemmi-the-glp-1-wars.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Hims & Hers 2025 Recap + 2026 Predictions","slug":"hims-hers-2025-recap-2026-predictions","published_at":"2026-01-21T13:13:42+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583/hims-hers-2025-recap-2026-predictions","url":"https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/Hims--Hers-2025-Recap--2026-Predictions-e3egqlv","duration_seconds":3411,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/hims-hers-2025-recap-2026-predictions/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hims-house-7026583/hims-hers-2025-recap-2026-predictions.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Shalin Shah - CEO of Marius Pharmaceuticals on the oral TRT partnership with Hims","slug":"shalin-shah-ceo-of-marius-pharmaceuticals-on-the-oral-trt-partnership-with-hims","published_at":"2025-11-10T14:27:55+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583/shalin-shah-ceo-of-marius-pharmaceuticals-on-the-oral-trt-partnership-with-hims","url":"https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/Shalin-Shah---CEO-of-Marius-Pharmaceuticals-on-the-oral-TRT-partnership-with-Hims-e3egqke","duration_seconds":1955,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/shalin-shah-ceo-of-marius-pharmaceuticals-on-the-oral-trt-partnership-with-hims/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hims-house-7026583/shalin-shah-ceo-of-marius-pharmaceuticals-on-the-oral-trt-partnership-with-hims.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Mark Mikhael & Joshua Fritzler (Olympia Pharmacy) - The MAHA PAC, GLP-1s, and peptides","slug":"mark-mikhael-joshua-fritzler-olympia-pharmacy-the-maha-pac-glp-1s-and-peptides","published_at":"2025-10-22T13:16:10+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583/mark-mikhael-joshua-fritzler-olympia-pharmacy-the-maha-pac-glp-1s-and-peptides","url":"https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/Mark-Mikhael--Joshua-Fritzler-Olympia-Pharmacy---The-MAHA-PAC--GLP-1s--and-peptides-e3egqlq","duration_seconds":3110,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/mark-mikhael-joshua-fritzler-olympia-pharmacy-the-maha-pac-glp-1s-and-peptides/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hims-house-7026583/mark-mikhael-joshua-fritzler-olympia-pharmacy-the-maha-pac-glp-1s-and-peptides.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Saad Alam (CEO, Hone Health) - Longevity, testosterone, & peptides","slug":"saad-alam-ceo-hone-health-longevity-testosterone-peptides","published_at":"2025-10-14T15:13:45+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583/saad-alam-ceo-hone-health-longevity-testosterone-peptides","url":"https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/Saad-Alam-CEO--Hone-Health---Longevity--testosterone---peptides-e3egqlp","duration_seconds":3085,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/saad-alam-ceo-hone-health-longevity-testosterone-peptides/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hims-house-7026583/saad-alam-ceo-hone-health-longevity-testosterone-peptides.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Lee Rosebush - The FDA's warning letters, \"Green List\", GLP-1s and peptides","slug":"lee-rosebush-the-fda-s-warning-letters-green-list-glp-1s-and-peptides","published_at":"2025-09-24T20:38:21+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583/lee-rosebush-the-fda-s-warning-letters-green-list-glp-1s-and-peptides","url":"https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/Lee-Rosebush---The-FDAs-warning-letters--Green-List--GLP-1s-and-peptides-e3egqlu","duration_seconds":3428,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/lee-rosebush-the-fda-s-warning-letters-green-list-glp-1s-and-peptides/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hims-house-7026583/lee-rosebush-the-fda-s-warning-letters-green-list-glp-1s-and-peptides.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Rob Leclerc - Why Hims is the ultimate VC-style 10X opportunity in the stock market","slug":"rob-leclerc-why-hims-is-the-ultimate-vc-style-10x-opportunity-in-the-stock-market","published_at":"2025-09-15T12:33:23+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583/rob-leclerc-why-hims-is-the-ultimate-vc-style-10x-opportunity-in-the-stock-market","url":"https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/Rob-Leclerc---Why-Hims-is-the-ultimate-VC-style-10X-opportunity-in-the-stock-market-e3egqlf","duration_seconds":3274,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/rob-leclerc-why-hims-is-the-ultimate-vc-style-10x-opportunity-in-the-stock-market/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hims-house-7026583/rob-leclerc-why-hims-is-the-ultimate-vc-style-10x-opportunity-in-the-stock-market.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Scott Brunner (Alliance for Pharmacy Compounding CEO) - Compounders vs. Big Pharma and GLP-1s","slug":"scott-brunner-alliance-for-pharmacy-compounding-ceo-compounders-vs-big-pharma-and-glp-1s","published_at":"2025-09-09T14:49:02+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583/scott-brunner-alliance-for-pharmacy-compounding-ceo-compounders-vs-big-pharma-and-glp-1s","url":"https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/Scott-Brunner-Alliance-for-Pharmacy-Compounding-CEO---Compounders-vs--Big-Pharma-and-GLP-1s-e3egql8","duration_seconds":3214,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/scott-brunner-alliance-for-pharmacy-compounding-ceo-compounders-vs-big-pharma-and-glp-1s/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hims-house-7026583/scott-brunner-alliance-for-pharmacy-compounding-ceo-compounders-vs-big-pharma-and-glp-1s.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Geoff Cook (Noom CEO) - The future of compounded GLP-1s","slug":"geoff-cook-noom-ceo-the-future-of-compounded-glp-1s","published_at":"2025-09-04T13:28:52+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583/geoff-cook-noom-ceo-the-future-of-compounded-glp-1s","url":"https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/Geoff-Cook-Noom-CEO---The-future-of-compounded-GLP-1s-e3egql7","duration_seconds":3254,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/geoff-cook-noom-ceo-the-future-of-compounded-glp-1s/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hims-house-7026583/geoff-cook-noom-ceo-the-future-of-compounded-glp-1s.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Dr. William Seeds - WTF are peptides? Are they legal? And where does Hims fit in?","slug":"dr-william-seeds-wtf-are-peptides-are-they-legal-and-where-does-hims-fit-in","published_at":"2025-08-27T12:23:38+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583/dr-william-seeds-wtf-are-peptides-are-they-legal-and-where-does-hims-fit-in","url":"https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/Dr--William-Seeds---WTF-are-peptides--Are-they-legal--And-where-does-Hims-fit-in-e3egqlj","duration_seconds":3991,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/dr-william-seeds-wtf-are-peptides-are-they-legal-and-where-does-hims-fit-in/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hims-house-7026583/dr-william-seeds-wtf-are-peptides-are-they-legal-and-where-does-hims-fit-in.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Shaun Noorian (Empower Pharmacy CEO) - GLP-1s, Patents, and the Future of Compounding","slug":"shaun-noorian-empower-pharmacy-ceo-glp-1s-patents-and-the-future-of-compounding","published_at":"2025-08-19T12:23:36+00:00","page_url":"https://stenobird.com/podcast/hims-house-7026583/shaun-noorian-empower-pharmacy-ceo-glp-1s-patents-and-the-future-of-compounding","url":"https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/Shaun-Noorian-Empower-Pharmacy-CEO---GLP-1s--Patents--and-the-Future-of-Compounding-e3egqle","duration_seconds":3913,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/shaun-noorian-empower-pharmacy-ceo-glp-1s-patents-and-the-future-of-compounding/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hims-house-7026583/shaun-noorian-empower-pharmacy-ceo-glp-1s-patents-and-the-future-of-compounding.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}]}